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 2009 EMBO Molecular MedicineKATP channels regulate insulin secretion from pancreatic b-cells. Loss- and gain-
of-function mutations in the genes encoding the Kir6.2 and SUR1 subunits of this
channel cause hyperinsulinism of infancy and neonatal diabetes, respectively. We
report two novel mutations in the gating loop of Kir6.2 which cause neonatal
diabetes with developmental delay (T293N) and hyperinsulinism (T294M). These
mutations increase (T293N) or decrease (T294M) whole-cell KATP currents,
accounting for the different clinical phenotypes. The T293N mutation increases
the intrinsic channel open probability (Po(0)), thereby indirectly decreasing
channel inhibition by ATP and increasing whole-cell currents. T294M channels
exhibit a dramatically reduced Po(0) in the homozygous but not in the pseudo-
heterozygous state. Unlike wild-type channels, hetT294M channels were acti-
vated by MgADP in the absence but not in the presence of MgATP; however, they
are activated by MgGDP in both the absence and presence of MgGTP. These
mutations demonstrate the importance of the gating loop of Kir channels in
regulating Po(0) and further suggest that Mg-nucleotide interaction with SUR1
may reduce ATP inhibition at Kir6.2.INTRODUCTIONNaturally occurring mutations can provide important insights
into ion channel function. This is especially true of mutations in
the ATP-sensitive potassium (KATP) channel, where mutations
can cause either too much or too little insulin secretion, givingtment of Physiology,
sula Medical School,
rmany.
Metabolism, Great
The Institute of Child
Children’s Hospital,
ersity Hospitals NHS
þ44 (0) 1865-285813;rise to hyperinsulinaemic hypoglycaemia of infancy and neonatal
diabetes, respectively (for a review, see Ashcroft, 2007).
KATP channels couple the metabolic state of the cell to its
electrical activity and are expressed in a wide range of cell types,
including neurones, muscle and endocrine tissue (reviewed by
Ashcroft, 2007; Nichols, 2006). In pancreatic b-cells, KATP
channels have a crucial role in insulin secretion (Fig S1 of
Supporting information). Their closure in response to metabo-
lically generated ATP produces membrane depolarization,
activation of voltage-gated Ca2þ channels, Ca2þ influx and
thereby insulin granule exocytosis (Ashcroft, 2007; Henquin,
2000; Nichols, 2006). Conversely, KATP channel opening leads to
membrane hyperpolarization, thus reducing Ca2þ influx and
switching off insulin secretion. This metabolic regulation is
mediated by changes in the intracellular concentration of
adenine nucleotides with ATP inducing KATP channel closure by
binding to the Kir6.2 subunit of the channel (Tucker et al, 1997)EMBO Mol Med 1, 166–177 www.embomolmed.org
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Figure 1. Partial pedigrees showing inheritance of KCNJ11 mutations.
Circles represent females and squares indicate males. An arrow with the letter
P points to the proband in each family. Filled symbols denote patients with
hyperinsulinism and vertical hatching represents neonatal diabetes.
Unaffected heterozygous mutation carriers are denoted by a dot. The
genotype is shown below each symbol: N denotes a normal allele and N/N a
normal genotype. The residue number and amino acid change are given for
mutation carriers.and Mg-nucleotides (MgATP, MgADP) stimulating channel open-
ing via the SUR1 subunit (Gribble et al, 1997; Nichols et al, 1996;
Shyng et al, 1997). The balance between these two opposing
effects of nucleotides determines the level of channel activity in
the cell.
Mutations in KCNJ11 and ABCC8, the genes encoding the
pore-forming (Kir6.2) and regulatory (SUR1) subunits, respec-
tively, of the KATP channel cause impaired insulin secretion.
Loss-of-function mutations cause hyperinsulinism of infancy
(HI), a condition in which insulin is continuously secreted,
independent of the plasma glucose level (De Leon & Stanley,
2007; Dunne et al, 2004). This is a serious condition because the
patient can suffer irreversible brain damage as a consequence of
the resulting hypoglycaemia. Most of the mutations have been
found in SUR1, but 24 have been identified in Kir6.2 (Flanagan
et al, 2009).
Gain-of-function mutations in KATP channel genes give rise to
neonatal diabetes, a rare disorder characterized by elevated
glucose levels within the first six months of life (for reviews, see
Ashcroft, 2007; Flanagan et al, 2009; Hattersley & Ashcroft,
2005). All mutations result in neonatal diabetes but this can
either be permanent (PNDM) or follow a remitting relapsing
course. In some cases, the patient experiences developmental
delay, epilepsy and muscle weakness in conjunction with
neonatal diabetes, a condition called DEND syndrome (Hatters-
ley & Ashcroft, 2005). In a milder form of this syndrome, known
as intermediate DEND syndrome (iDEND), the patients are not
affected by epilepsy. Although mutations in either Kir6.2 or
SUR1 can cause all these different conditions, both iDEND and
DEND syndromes are more commonly associated with Kir6.2
mutations than SUR1 mutations. All Kir6.2 mutations cause a
reduced KATP channel sensitivity to inhibition by MgATP, but
this is greater for mutations that cause the more severe disease
phenotypes (Koster et al, 2008; Masia et al, 2007; Proks et al,
2005b; Shimomura et al, 2006). In b-cells, the increased KATP
current impairs insulin release, thus causing diabetes (Girard et
al, 2009; Koster et al, 2000). In neurones, it leads to the
neurological symptoms of DEND syndrome.
In this paper, we identify two novel KCNJ11 mutations in
patients with the opposite phenotypes of iDEND (T293N) and HI
(T294M). These mutations lie side-by-side in the gating loop of
Kir6.2. Functional analysis revealed that the T293N mutation
produces a marked reduction in KATP channel inhibition by
MgATP, due to an increase in the intrinsic channel open
probability (Po(0)). This leads to a large increase in the resting
whole-cell KATP current, which can account for the iDEND
phenotype of the patient. In contrast, the T294M mutation
reduced Po(0) to unmeasurable levels, thereby reducing the
whole-cell current and stimulating insulin secretion.RESULTS
Patient characteristics and genetics
A novel heterozygous KCNJ11 mutation (c.878C>A;
p.Thr293Asn or T293N) was identified in a girl born to second
cousins of Turkish descent (Fig 1, case 1). DNA was notwww.embomolmed.org EMBO Mol Med 1, 166–177available from the parents but neither of them is known to
be diabetic. The proband had a birth weight of 2.6 kg and
presented with diabetic ketoacidosis at 10 weeks of age. She has
developmental delay with severe muscle weakness in the
trunk and legs, but no epilepsy, indicating she has iDEND
syndrome. She was initially treated with insulin but glibencla-
mide (1–1.1 mg/kg/day) was added from 15 months of age,
which enabled the insulin dose to be reduced from 0.9 to 0.5 U/
kg/day. Improvements in her walking, speech and fine motor
skills were noted after starting glibenclamide.
Two patients with congenital hyperinsulinism (Fig 1, cases 2
and 3) were heterozygous for a second KCNJ11 mutation,
T294M (c.881C>T; p.Thr294Met). Case 2 is a female born at
38 weeks gestation with a birth weight of 4.1 kg, who developed
severe hypoglycaemia soon after birth. She required high
concentrations of intravenous glucose infusions to maintain
normoglycaemia and a hypoglycaemia screen at 10 days of age
confirmed hyperinsulinism with a plasma insulin concentration
of 110 pM at a blood glucose concentration of 1.2 mM. She did
not respond to diazoxide treatment and underwent a sub-total
pancreatectomy at four weeks of age. Histological analysis
showed hyperplasia throughout the pancreas with enlarged 2009 EMBO Molecular Medicine 167
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168nuclei. The T294M mutation was inherited from her unaffected
father: her unaffected paternal grandmother also carried the
mutation (Fig 1, case 2). Analysis of microsatellite markers
across the chromosome 11p15.1–11p15.5 region showed loss of
heterozygosity of the maternal allele consistent with a giant
focal lesion. The heterozygous germline T294M mutation is
therefore homozygous within the pancreas.
Case 3 is amale born at 37weeks gestationwith a birthweight
of 4.8 kg. Hyperinsulinaemic hypoglycaemia was diagnosed at
one week of age (glucose 2.3 mM, insulin 531 pM) and
euglycaemiawas achievedwith diazoxide therapy (starting dose
10 mg/kg/day, current dose at 19 months of age is 4 mg/kg/
day). His mother is also heterozygous for the T294M mutation:
she had glycosuria during pregnancy but has no history of
hypoglycaemia. A second mutation was not detected within the
coding region of the ABCC8 gene.
Effects of T293N and T294M mutations on whole-cell KATP
currents
To determine the molecular mechanism of the disease, wild-
type and mutant KATP channels were expressed in Xenopus
oocytes. Under resting conditions, wild-type KATP channels are
closed due to the high intracellular ATP concentration ([ATP]i)
(Fig 2A and B). However, substantial currents were activated by 2009 EMBO Molecular Medicinethe metabolic inhibitor sodium azide, which lowers [ATP]i and
thus opens KATP channels. The ability of the KATP channel
blockers glibenclamide (Fig 2A and B) and tolbutamide (Fig 2C,
Fig S2 of Supporting information) to inhibit these currents
confirmed their identity.
In contrast to wild-type channels, substantial resting Kþ
currents were present in oocytes expressing homomeric Kir6.2-
T293N/SUR1 (homT293N) channels (Fig 2A–C). These currents
were further increased by azide suggesting that homT293N
channels are not fully open at resting [ATP]i in the oocyte.
Coinjection of wild-type and mutant Kir6.2, to simulate the
heterozygous state, produced resting currents (hetT293N) that
weremuch greater thanwild-type and further increased by azide
(Fig 2A–C). Mutant channels were significantly less sensitive to
both glibenclamide and tolbutamide at concentrations that
maximally block wild-type channels. Glibenclamide (100 mM)
blocked wild-type channels by 96 1% (n¼ 5) compared with
66 9% (n¼ 5) for hetT293N channels and 59 4% (n¼ 5) for
homT293N channels (Fig 2B). Inhibition by 0.5 mM tobutamide
was 97 1% (n¼ 5) for wild-type channels, 36 2% (n¼ 5) for
hetT293N channels and 24 3% (n¼ 5) for homT293N
channels (Fig 2C). Thus the T293N mutation appears to
induce a greater reduction in block by tolbutamide than
glibenclamide.Figure 2. Effects of the T293N and T294M
mutations on the whole-cell currents.
A. Representative wild-type, hetT293M and
homT293M whole-cell currents evoked by a
voltage step from 10 to 30 mV. The bars
indicate the application of 3 mM azide or
100 mM glibenclamide (glib).
B–C. Mean steady-state whole-cell KATP channel
current (as indicated) before (white bar) and
after the application of 3 mM azide (grey bar)
and in the presence of 3 mM azide and either
100 mM glibenclamide (B, black bar) or 0.5 mM
tolbutamide (C, black bar). Note B and C were
separate sets of experiments using different
oocytes. The number of oocytes is indicated
below the bar.
D. Mean steady-state whole-cell evoked by a
voltage step from 10 mV to 30 mV before
(white bar) and after application of 3 mM azide
(light grey bar), in the presence of 3 mM azide
and 0.34 mM diazoxide (dark grey bar) and in
the presence of 3 mM azide and 0.5 mM
tolbutamide (black bar).
EMBO Mol Med 1, 166–177 www.embomolmed.org
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to open in response to either azide or the KATP channel opener
diazoxide (Fig 2D). Resting hetT294M currents were also
unmeasureable, and although some current was activated by
both azide and diazoxide it was significantly less than that
observed for wild-type channels (66% and 51% smaller,
respectively: Fig 2D, Fig S2 of Supporting information). The
currents were fully blocked by tolbutamide.
These differences in the magnitude of the whole-cell currents
are consistent with the clinical phenotypes associated with the
mutations.
T293N channels exhibit reduced ATP sensitivity
The increase in resting whole-cell KATP currents suggests that
the T293N mutation may reduce channel inhibition by ATP, as
found for other iDEND mutations. To explore this idea, we
measured ATP-concentration response curves in inside-out
membrane patches. Because ATP does not interact with SUR1 to
stimulate channel activity in the absence of Mg2þ (Gribble et al,
1998), experiments were first carried out in the absence ofMg2þ:
this enables the effect of the mutation on ATP block at Kir6.2 to
be studied in isolation from Mg-nucleotide activation at SUR1.
Figure 3A shows that both homT293N and hetT293N currents
were less ATP sensitive: half-maximal block (IC50) was
produced by 778 mM, 37 mM and 6 mM ATP for homT293N,www.embomolmed.org EMBO Mol Med 1, 166–177hetT293N and wild-type channels respectively (Table 1). The
concentration–response curve for homT293N currents was best
fit by assuming that a small fraction (4%) of channels are never
closed by ATP. These data indicate that the mutation decreases
the ATP sensitivity of the channel, at least in part, via Kir6.2.
In the intact pancreatic b-cell, the effect of the T293N
mutation on ATP inhibition at Kir6.2 will be modified by the
stimulatory effect of MgATP at SUR1. Thus, we next compared
ATP concentration–response curves in the presence of Mg2þ
(Fig 3B). HomT293N currents were significantly less ATP
sensitive than in the absence of Mg2þ, being blocked less than
20% even at MgATP concentrations as high as 10 mM. The IC50
for hetT293N channels (324 mM)was also less than that of wild-
type channels (17 mM; Table 1). As found for other mutations
causing neonatal diabetes (Proks et al, 2005a), the increase in
the IC50 produced by Mg
2þ was greater for hetT293N channels
(nine-fold) than for wild-type channels (3-fold) (compare Fig 4A
and B). In addition, a large fraction of hetT293N current was
unblocked at 3 mM MgATP (34 2%, n¼ 5).
As Mg2þ is always present inside the cell, and ATP
concentrations probably lie above 1 mM in physiological
conditions (Gribble et al, 2000), these results suggest that there
will be a substantial increase in the resting whole-cell KATP
currents for both hetT293N and homT293N channels, as
observed experimentally (Fig 2A–C).Figure 3. Effects of the T293N mutation on
KATP channel ATP sensitivity. ATP concentration–
response relations in the absence (A) and presence
(B) of Mg2þ.
Left: KATP currents recorded in response to voltage
ramps from 110 to þ110 mV in an inside-out
patch excised from oocytes expressing wild-type
or homT293N channels. The dashed line indicates
the zero current level. The bar indicates
application of 100 mM ATP (A) or 1 mM ATP (B).
Right: Mean relationships between [ATP] and KATP
conductance (G), expressed relative to that in the
absence of nucleotide (Gc), for Kir6.2/SUR1 (*,
n¼ 5), and heterozygous (, n¼ 6) or homomeric
(&, n¼5) Kir6.2-T293N/SUR1 channels in the
absence of Mg2þ (A); or for wild-type (*, n¼ 8),
hetT293N (, n¼ 5) or homT293N (&, n¼ 5)
currents in the presence of Mg2þ (B). The lines are
drawn to equation 1, with the following
parameters. A: wild-type (IC50¼5 mM, h¼0.9),
hetT293N (IC50¼36 mM, h¼ 1.2), homoT293N
(IC50¼ 793 mM, h¼ 1.5, a¼0.03). B: Kir6.2/
SUR1 (IC50¼ 14 mM, h¼1) and het293N
(IC50¼ 391 mM, h¼0.7, a¼ 0.2). The line through
the hom293N data is drawn by hand.
 2009 EMBO Molecular Medicine 169
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Figure 4. Effects of Mg2R on ATP sensitivity. Comparison of ATP
concentration–response curves of wild-type (A) het293N (B) and hetT294M
(C) channels in the absence (*) and presence () of Mg2þ. Same data as in
Fig 2 and 3.
Table 1. Characteristics of mutations
IC50 (mM; 0 mM Mg
2þ) IC50 (mM; 2 mM Mg
2þ) %I (3 mM MgATP)
WT 61 (n¼ 5) 172 (n¼ 8) 0.8 0.3 (n¼8)
hetT293N 377 (n¼ 6) 32448 (n¼5) 342 (n¼ 5)
homT293N 77892 (n¼ 5) n.m. >90%
IC50 (mM; 0 mM Mg
2þ) IC50 (mM; 2 mM Mg
2þ) %I (3 mM MgATP)
WT 6 1 (n¼10) 16 2 (n¼10) 0.7 0.3 (n¼ 10)
hetT294M 63 (n¼ 6) 72 (n¼10) 1.0 0.4 (n¼ 10)
Values in parentheses indicate the number of oocytes. n.m., not meausureable. %I¼ current recorded in an inside-out patch in the presence of 3 mM MgATP
expressed as a percentage of that in the absence of MgATP. The values were calculated from the fit of equation 1 to the data obtained for individual oocytes.
170  2009 EMBO Molecular MedicineT293N channels have an increased intrinsic open probability
Mutations that reduce the ATP sensitivity of the KATP channel
can act by impairing ATP binding or transduction, or by
influencing the intrinsic (ligand-independent) gating of the
channel (Ashcroft 2007; Masia et al, 2007; Proks et al, 2005b;
Shimomura et al, 2006). We therefore examined the effect of the
T293N mutation on the single-channel kinetics. Experiments
were carried out in the absence of ATP, where intrinsic gating
can be assessed. We found that the intrinsic Po(0) was markedly
increased by the T293N mutation (Fig 5), being 0.87 0.03
(n¼ 5) for homT293N compared with 0.27 0.04 (n¼ 6) for
wild-type channels. This increase in Po(0) is sufficient to account
for the lower ATP sensitivity of the mutant channel (Enkvetch-
akul et al, 2000; Proks et al, 2005b).Figure 5. The T293N mutation increases Po(0). Representative single KATP
channel currents recorded at 60 mV from inside-out patches from oocytes
expressing SUR1 plus either Kir6.2 or Kir6.2-T293N. The dashed line indicates
the zero current level.The increased Po(0) is produced by an increase in the duration
of the bursts of openings and a decrease in the duration and
frequency of the long closed states. Mean burst duration was
16 3ms (n¼ 5) for wild-type channels and 399 19ms (n¼ 5)
for homT293N channels. Wild-type channels had two interburst
states of 4.2 1.3 and 59 3 ms (n¼ 5), with relative
frequencies of 10 and 5% respectively (the balance being made
up of intraburst closed times). In contrast, homT293N channels
had a single interburst state of 13 1 ms (n¼ 5) with a
frequency of 0.9%.EMBO Mol Med 1, 166–177 www.embomolmed.org
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No currents were detected in inside-out patches excised from
oocytes expressing homT294M channels, even in the absence of
added nucleotide. This might reflect a reduced density of mutant
channels in the plasma membrane or the mutant channels could
be present but permanently closed (due to a markedly decreased
Po(0)). To determine which of these possibilities was correct,Figure 6. Effects of the T294M mutation on channel density and ATP
sensitivity.
A. Mean surface expression for wild-type and mutant KATP channels in
COS-7 cells, measured using a chemiluminnescence assay. Wild-type
Kir6.2 was expressed alone or in combination with SUR1.
B, C. Mean relationships between [ATP] and KATP conductance (G) expressed
relative to the conductance in the absence of nucleotide (Gc) for Kir6.2/
SUR1 (*, n¼ 10), and hetKir6.2-T294M/SUR1 (, n¼ 6) channels in the
absence of Mg2þ (B); or for Kir6.2/SUR1 (*, n¼10), and heterozygous
(, n¼ 10) Kir6.2-T294M/SUR1 currents in the presence of Mg2þ (C).
The lines are drawn to equation 1, with the following parameters.
B: Kir6.2/SUR1 (IC50¼ 5 mM, h¼1.1), hetT294M (IC50¼4 mM, h¼ 0.7).
C: Kir6.2/SUR1 (IC50¼ 14mM, h¼1.1), hetT294M (IC50¼ 6 mM, h¼ 0.7).
www.embomolmed.org EMBO Mol Med 1, 166–177we measured the surface expression of T294M channels in
COS-7 cells.
As previously reported (Zerangue et al, 1999), Kir6.2 did not
reach the surface membrane in the absence of SUR1, but was
easily detected when Kir6.2 and SUR1 were co-expressed
(Fig 6A). Co-expression of SUR1 with Kir6.2-T294M resulted in
less surface expression, but this was still substantial. This
suggests that the lack of homT294M currents observed in
excised patches is, in part, due to a lower channel density,
caused by impaired trafficking of channels to the plasma
membrane. Nevertheless, the fact that the expression is 60% of
wild-type indicates many homT294M channels are present, but
that they are closed (i.e. they have a Po(0) of zero).
In the heterozygous state, there will be a mixed population of
channels that contain a variable number of mutant subunits
(from 0 to 4). The Po(0) of hetT294M channels was therefore
measured in multi-channel patches (Fig S3 of Supporting
information). This represents the average Po(0) of the channel
population: it was not different from wild-type, being
0.34 0.03 (n¼ 15) for hetT294M and 0.27 0.03 (n¼ 11)
for wild-type channels.
ATP-sensitivity of hetT294M channels
Although no homT294M currents were detected in inside-out
patches, large hetT294M currents were observed. Figure 6B and C
shows that although the ATP sensitivity of hetT294M currents
was similar towild-type in the absence ofMg2þ (IC50 6mMin both
cases), it was greater than wild-type in the presence of Mg2þ
(IC50¼ 7 and 16 mM, respectively) (Table 1). However, there
was no obvious difference in ATP block at ATP concentrations
>100 mM. This reflects a decrease in the slope factor (Hill
coefficient) of theATP concentration–inhibition curve of hetT294M
channels both in the presence and in the absence of the cation.
Interestingly, unlike both wild-type and hetT293N currents,
there was no significant effect of Mg2þ on the ATP sensitivity of
hetT294M currents (Fig 4C). This suggests that MgATP and/or
MgADP activation by SUR1 is impaired by the T294M mutation.
We therefore tested the ability of MgADP (0.1 mM) to activate
hetT294M channels both in the absence and presence of 0.1 mM
MgATP (Fig 7A). MgADP alone stimulated channel activity to
the same extent as for wild-type channels. In striking contrast to
wild-type channels, however, MgADP did not activate
hetT294M channels preblocked by MgATP.
As bothMgATP andMgADP exert an inhibitory effect at Kir6.2
and a stimulatory effect at SUR1, we next examined the effects of
GDP and GTP. At a concentration of 100 mM, these nucleotides
have little inhibitory effect at Kir6.2 but stimulate channel activity
via SUR1 (Trapp et al, 1997). As Fig 7B shows,MgGDP stimulated
channel activity both in the absence and presence ofMgGTP. This
suggests that nucleotide binding, hydrolysis and transduction by
SUR1 are unaffected by the T294M mutation.DISCUSSION
In this paper, we demonstrate that mutation of two adjacent
residues in the cytosolic domain of Kir6.2 either increases 2009 EMBO Molecular Medicine 171
Research Article
Gating loop mutations in Kir6.2
Figure 7. Mean currents recorded for the wild-type and mutation in the
presence of various Mg-nucleotides.
A. Mean wild-type (white bar, n¼17) and hetT294M (black bar, n¼ 12)
currents recorded in the presence of 0.1 mM MgATP, 0.1 mM MgADP or
0.1 mM MgATP plus 0.1 mM MgADP.
B. Mean wild-type (white bar, n¼6) and hetT294M (black bar, n¼7)
currents recorded in the presence of 0.1 mM MgGTP, 0.1 mM MgGDP or
0.1 mM MgGTP plus 0.1 mM MgGDP. Currents (G) are expressed relative to
the mean of the currents recorded in control solution (Gc) before and after
the application of nucleotide.
172(T293N) or decreases (T294M) the KATP current, consistent with
the opposite phenotypes of iDEND and hyperinsulinism in
patients carrying these mutations.
Our data also show that in the homozygous state, the T293N
and T294M mutations have opposite effects on KATP channel
open probability. This provides further support for the idea that
residues between 292 and 297 serve as a ’gating loop’ that forms
a cytoplasmic gate to the pore (Nishida et al, 2007; Pegan et al,
2005; Proks et al, 2005b).
Functional implications: the T293N mutation
The large amplitude of hetT293N currents recorded in inside-out
patches exposed to physiological levels of MgATP explains the
dramatic increase in the resting whole-cell KATP currents. In
pancreatic b-cells, a similar increase in the KATP current would 2009 EMBO Molecular Medicinebe expected to cause membrane hyperpolarization and reduce
or abolish the membrane depolarization evoked by glucose.
This would prevent electrical activity, Ca2þ influx and insulin
secretion, and can thereby account for the diabetic phenotype of
the patient (Fig S1D of Supporting information).
The very large currents recorded in the presence of MgATP
are entirely consistent with the neurological symptoms of the
patient. Previous studies have shown that mutations which
cause DEND syndrome give rise to heterozygous KATP currents
that are much less sensitive to MgATP inhibition thanmutations
associated with neonatal diabetes alone (Ashcroft, 2007). This is
probably because KATP channels are normally shut in many
muscle and nerve tissues and open only under metabolic stress
(Nichols, 2006). Thus, a greater reduction in ATP sensitivity is
required to increase the resting KATP current sufficiently to
influence electrical activity in these cells.
For mutations that cause DEND syndrome, 26–40% of the
heterozygous current is not blocked by 3mMMgATP, compared
to 12–20% formutations causing iDEND, 4–10% (in general) for
mutations causing neonatal diabetes alone and <1% for wild-
type channels (Ashcroft, 2007). The T293N mutation results in
heterozygous currents of a magnitude (34%) similar to those
that cause DEND syndrome. It is therefore surprising that the
patient does not have epilepsy in addition to severe muscle
weakness and developmental delay. However, the L164P
mutation, which gives rise to unblocked currents of similar
magnitude (34%) at 3 mM MgATP, also produces neonatal
diabetes but not epilepsy (Tammaro et al, 2008). The T293N
mutation is therefore a second case of a functionally severe
mutation that does not cause epilepsy.
Functional implications: the T294M mutation
Case 2 is essentially homozygous for the T294Mmutation in her
b-cells due to deletion of the maternal allele throughout the
whole pancreas. The lack of any azide-activated whole-cell
current found for homT294M channels thus explains the
congenital hyperinsulinism of this patient. A similar loss of
the KATP current in her b-cells would produce a permanent
membrane depolarization, irrespective of the blood glucose
level. This would stimulate electrical activity and calcium
influx, and thus give rise to persistent and unregulated insulin
secretion (Fig 1C of Supporting information). The failure of case
2 to respond to diazoxide therapy is consistent with the in vitro
results for homT294M channels.
Three heterozygous carriers of the T294M mutation were
unaffected: the father and paternal grandmother of case 2, and
the mother of case 3. This suggests that the reduction in whole-
cell currents seen for het294M channels does not impair insulin
secretion enough to produce a phenotype. It also suggests that
case 3 must possess a second, as yet unidentified, mutation that
contributes to his disease. This is assumed to be a milder
mutation that retains sensitivity to diazoxide.
Molecular mechanism of the T293N mutation
The increased KATP current produced by the T293N mutation
results from a decreased sensitivity to MgATP block, which is
due to two mechanisms. The first is a reduced ability of ATP toEMBO Mol Med 1, 166–177 www.embomolmed.org
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present in the absence of Mg2þ. This can be accounted for by the
large increase in intrinsic Po(0). Second, the enhanced reduction
in ATP sensitivity in the presence of Mg2þ argues that the
stimulatory actions of MgATP, mediated via SUR1, are
enhanced by the mutation. This is also found for some other
PNDM mutations (Proks et al, 2005a).
Molecular mechanism of the T294M mutation
Our results indicate that the lack of homT294M currents observed
in whole-cell recordings and inside-out patches exposed to
nucleotide-free solution reflects both a reduction in channel
trafficking to the plasmamembrane and amarkedly reduced open
Po(0). As channel density is 60% of that of wild-type but no
currents are seen in either cell-attached or excised membrane
patches, we infer that all channels are closed (i.e. Po(0) is close to
zero). Thus the T294M mutation appears to affect the intrinsic
gating of the channel, but in the opposite direction to the T293N
mutation. A KCNJ11 mutation (F55L) associated with HI that
markedly decreases, but does not abolish, Po(0) in the
homozygous channel has been reported previously: however,
this mutation lies within the slide helix (Lin et al, 2006).
There was no change in the Po(0) of hetT294M channels. This
suggests that mutant subunits do not exert a measurable
influence on Po(0) when combined with wild-type subunits: note
that any homT294M channels will be silent and thus not
contribute to Po(0) and that abolition of the stimulatory effect of
MgADP in the presence of MgATP implies that the heterozygous
channel population must contain only a small number of
homomeric wild-type channels. The fact that the Po(0) of
heteromeric T294M channels is unaffected contrasts with
mutations that enhance Po(0), which appear to have an additive
effect on the energy of the open state (Proks et al, 2005b).
The reduction in hetT294M whole-cell currents presumably
reflects, at least in part, a reduced channel density. However, the
magnitude of this reduction (60%) is greater than can be
accounted for by a decrease in channel density, even if this is
assumed to be similar to that of homT294 channels (40%). This
may reflect the fact that unlike wild-type channels, the ATP
sensitivity is not reduced by Mg2þ. This is due to the inability of
MgADP to enhance channel activity in the presence of MgATP.
Several SUR1 mutations causing HI act by preventing MgADP
activation of the channel but they do so in both the absence and
presence of MgATP (Nichols et al, 1996; Shyng et al, 1998; Yan
et al, 2007). This leads to reduced levels of channel activity
under conditions of low metabolism, and thus to stimulation of
insulin secretion. The T294Mmutation is the first mutation to be
shown to selectively abolish the ability of MgADP to stimulate
channel activity in the presence of MgATP.
Our data suggest that Mg-nucleotide binding, hydrolysis and
transduction by SUR1 are unaffected by the T294M mutation,
because MgGDP was able to activate the channel in both the
absence and presence of MgGTP and because MgADP was able to
activate hetT294M currents in the absence of MgATP to the same
extent aswild-type channels.We do not know the exactmolecular
mechanism underlying the inability of MgADP to stimulate
hetT294M channels in the presence of MgATP. However, onewww.embomolmed.org EMBO Mol Med 1, 166–177possibility is suggested by the fact that unlike MgATP, GTP and
GDP cause little blockage at Kir6.2 (Trapp et al, 1997).
We hypothesize that (in addition to its well-characterized
stimulatory effect on KATP channel activity), SUR1 may impair
ATP inhibition of wild-type Kir6.2, but not that of hetT294M, via
a Mg-dependent mechanism. This phenomenon would not be
evident in the presence of guanine nucleotides, which cause
little blockage at Kir6.2 (Trapp et al, 1997). In the presence of
MgATP and MgADP, the level of wild-type channel activity will
reflect the balance between the stimulatory effects of Mg-
nucleotides (mediated by SUR1) and inhibition via Kir6.2: we
propose that SUR1 alleviates some of the inhibition of at Kir6.2.
HetT294M channels will also be activated by SUR1 and blocked
by ATP binding to Kir6.2, but as SUR1 is unable to alleviate
inhibition at Kir6.2 the overall current magnitude is less than
that of wild-type channels.
The ability of SUR1 to alleviate ATP inhibition at Kir6.2 might
also contribute to the reduction in ATP sensitivity seen for wild-
type channels in the presence of Mg2þ: and suppression of this
effect by the T294M mutation could account for the lack of
change in ATP sensitivity in Mg2þ solution. It is also intriguing
to speculate that the greater reduction in ATP block seen for
hetT293N and homT293N channels in the presence of Mg2þ
might be due to the opposite effect—a reduction in the ability of
SUR1 to enhance ATP block at Kir6.2.
Structural considerations
In a molecular model of Kir6.2, both mutations lie within the
gating loop (G-loop) of the cytoplasmic domain of the channel, far
away from the ATP-binding site (Antcliff et al, 2005; Fig 8). In the
2.2 A˚ crystal structure of a chimeric Kir channel, the G-loop forms
a gate at the apex of the cytoplasmic pore (Nishida et al, 2007). In
its constricted conformation, the pore is toonarrow for dehydrated
Kþ ions to pass through, whereas in the dilated conformation, a
mostly hydrated Kþ ion should be able to pass. The G-loop
encompasses the region overwhich dilation and contraction occur
and in Kir6.2 it includes the residues 289–297. The functional
significance of the G-loop in Kir6.2 is demonstrated by the fact that
many residues within this loop are mutated in human disease. In
addition to the T293 and T294 mutations described here,
mutations at E292 (G) and I296 (L) have previously been reported
to cause PNDM and DEND syndrome respectively (Proks et al,
2005b; Girard et al, 2006). All mutations in this region affect
channel gating with neonatal diabetes mutations increasing Po(0)
and, as shown here, HI mutations reducing Po(0).
Our results suggest that in the homomeric channel, the
E292G, T293N and I296L mutations stabilize the dilated
conformation of the channel, whereas the T294M mutation
locks it into the constricted state.
In an atomic resolution model of Kir6.2 (Antcliff et al, 2005),
the side chain of residue T293 points up from the gating loop
towards the slide helix of the adjacent subunit (Fig 8). The
hydroxyl group of the side chain lies within 4 A˚ of three slide
helix residues: F60, T61, and V64. As asparagine has a longer
side chain than threonine and is able to form hydrogen
bonds, it is likely to make additional contacts with the slide
helix. 2009 EMBO Molecular Medicine 173
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Figure 8. Location of residues T293 and T294 in a molecular model of
Kir6.2.
A. Location of residues 293 and 294 in a molecular model of Kir6.2 (Antcliff
et al, 2005). For clarity, only two transmembrane domains (TMs) and two
cytosolic domains are illustrated. T293 and T294 are shown in red and
blue, respectively. ATP is shown in purple.
B. Close-up of interactions of T293 and T294 with neighbouring residues
(indicated in cpk colours). The main chains of the different subunits are
indicated in purple and blue.
174The side chain of residue T294 points away from the slide
helix and the hydroxyl group does not lie within 4 A˚ of any
residue (other than its neighbours). Replacement with methio-
nine extends the length and mass of the side-chain, bringing it
within 4 A˚ of the cytosolic end of the second transmembrane
domain of the same subunit.
The Kir6.2 model of Antcliff et al (2005) most closely
resembles the dilated (open) conformation of the cytosolic pore
of the chimeric Kir channel (Nishida et al, 2007). Thus, we can
speculate that interactions between the gating loop and slide
helix may promote channel opening, whereas interaction of the
gating loop with the lower end of TM2 may promote the closed
state.
Clinical implications
Sulphonylureas are an effective therapy for most patients with
KCNJ11mutations that cause neonatal diabetes alone, andmany
have now successfully transferred from insulin to sulphonylur-
eas (Pearson et al, 2006). In functional studies, KATP channels 2009 EMBO Molecular Medicinecarrying these mutations remain as sensitive to tolbutamide
inhibition as wild-type channels, being 87–96% inhibited by
0.5 mM tolbutamide (Pearson et al, 2006). However, like many
mutations that cause DEND syndrome, hetT293N channels were
substantially less sensitive to tolbutamide (36% block).
Glibenclamide also blocked hetT293N channels less potently
(66% block compared to 96% for wild-type channels).
The magnitude of the in vitro response to glibenclamide is
consistent with the patient’s partial response to glibenclamide
therapy. Glycaemic control is currently maintained on a
combined treatment regime of insulin (0.5 U/kg/day) and
glibenclamide (1.1 mg kg/day), but she has shown improve-
ment in neurological functions since the commencement of
treatment with sulphonylureas. Similarly, tolbutamide was able
to control infantile spasms for 3 months in a child with a Kir6.2-
C166F mutation, despite some insulin still being needed to
control her diabetes (Bahi-Buisson et al, 2007). These results
suggest that even for the most severe mutations it is always
worth trying sulphonylurea therapy, as it may improve the
neurological symptoms even if it is unable to control the
diabetes.MATERIALS AND METHODS
Mutation detection
Genomic DNA was extracted from peripheral leukocytes using
standard procedures. The KCNJ11 minimal promoter region, the
single-coding exon of KCNJ11, and the 39 exons of ABCC8 were
amplified in six fragments by the polymerase chain reaction (PCR;
primer sequences are available on request). Unidirectional sequencing
was performed using universal M13 primers and a Big Dye Terminator
Cycler Sequencing Kit v3.1 (Applied Biosystems, Warrington, UK)
according to the manufacturer’s instructions. Reactions were analysed
on an ABI 3730 Capillary sequencer (Applied Biosystems, Warrington,
UK) and sequences were compared to the published sequence
(NM_00525 and to NM_000352.2) using Mutation Surveyor v2.61
(SoftGenetics, PA, USA).
Loss of heterozygosity was investigated by microsatellite analysis of
DNA extracted from paraffin-embedded pancreatic tissue and
peripheral leukocytes. Six markers (D11S2071, D11S2344,
D11S2347, D11S419, D11S1397 and D11S902) were amplified
by PCR and allele peak heights were compared using GeneMarker
v1.7 (SoftGenetics, PA, USA). Primer sequences are available on
request.
Molecular biology and oocyte preparation
Human Kir6.2 (Genbank NM000525; E23 and I337) and rat SUR1
(Genbank L40624) were used. Site-directed mutagenesis of Kir6.2,
synthesis of capped mRNA and preparation and injection of Xenopus
laevis were performed as previously reported (Proks et al, 2005a,b).
Oocytes were coinjected with2 ng of SUR1 mRNA and 0.1 ng wild-
type or mutant Kir6.2 mRNA. To simulate the heterozygous state,
SUR1 was co-expressed with a 1:1 mixture of wild-type and mutant
Kir6.2. For each batch of oocytes, all mutations were injected to enable
direct comparison of their effects. Oocytes were maintained in Barth’s
solution and studied 1–7 days after injection.EMBO Mol Med 1, 166–177 www.embomolmed.org
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The paper explained
PROBLEM:
The ATP-sensitive potassium (KATP) channel is a tiny, gated pore
in the cell membrane of insulin-secreting b-cells that regulates
insulin secretion. When this channel is shut, insulin is secreted
and when it is open insulin secretion is prevented. Channel
activity is regulated by changes in blood glucose levels: when
blood glucose levels rise (as after a meal), ATP is generated by the
b-cell, and binds to the channel and causes its closure. This
stimulates insulin release and the hormone then restores the
blood glucose concentration to its resting level. Mutations in the
KATP channel are a common cause of neonatal diabetes (diabetes
that develops within the first six months of life) and of
hyperinsulinism of infancy (in which insulin secretion is
unregulated leading to very low blood glucose levels). The aim of
this paper is to identify the molecular mechanism underlying two
novel disease-causing mutations in the pore-forming subunit of
the KATP channel (Kir6.2 or KCNJ11).
RESULTS:
We describe here a novel Kir6.2 mutation (T293N) that causes
neonatal diabetes in conjunction with developmental delay and
muscle weakness. Functional analysis revealed that the mutant
channel failed to close in response to ATP. This is expected to
impair insulin secretion, thus causing diabetes. It might also
reduce the activity of brain neurons, thus leading to the
neurological problems experienced by the patients. Treatment
with glibenclamide (a sulphonylurea drug known to bind to and
close the KATP channel) partially blocked the KATP channel in
functional studies. It also reduced the insulin requirement of the
patient and improved walking, speech and fine motor skills. We
also identified a loss-of-function mutation in the same gene at
the adjacent residue (T294M) that was associated with
hyperinsulinism of infancy. This mutation caused the channel to
remain shut even when ATP or metabolism were low. This is
expected to cause continuous insulin secretion accounting for
the disease phenotype.
IMPACT:
These results provide novel insights into how the opening and
closing of the KATP channel is regulated.Electrophysiology
Whole-cell currents were recorded using a 2-electrode voltage-clamp
in response to voltage steps of 20 mV from a holding potential of
10 mV, in a solution containing (in mM): 90 KCl, 1 MgCl2, 1.8 CaCl2,
5 HEPES (pH 7.4 with KOH). Metabolic inhibition was induced by
3 mM Na-azide; and 0.5 mM tolbutamide or 100 mM glibenclamide
was used to block the KATP channel, as indicated. Diazoxide (340 mM)
was used to activate the KATP channels. Macroscopic currents
were recorded from giant inside-out patches. The pipette solution
contained (mM): 140 KCl, 1.2 MgCl2, 2.6 CaCl2, 10 HEPES
(pH 7.4 with KOH). The Mg-free internal (bath) solution contained
(mM): 107 KCl, 1 K2SO4, 10 EGTA, 10 HEPES (pH 7.2 with KOH) and
K2ATP, as indicated. The Mg-containing solution was made by
adding 2 mM MgCl2 to Mg-free solution and using MgATP rather
than ATP.
The macroscopic slope conductance was measured between 20
and 100 mV, in response to 3 s voltage ramps from 100 to
þ110 mV (holding potential 10 mV). To control for possible
rundown, Gc was taken as the mean of the conductance in the
control solution before and after ATP application. ATP concentration–
response curves were fit with a modified Hill equation
G=Gc ¼ aþ ð1 aÞ=ð1þ ð½ATP=IC50ÞhÞ; ð1Þ
where [ATP] is the ATP concentration, IC50 is the [ATP] at which
inhibition is half maximal, h is the slope factor (Hill coefficient) and a
represents the fraction of unblocked current at saturating [ATP] (a¼0
except where specified).www.embomolmed.org EMBO Mol Med 1, 166–177Single-channel currents were recorded at 60 mV from inside-out
patches and analysed by using a combination of Clampfit (Axon
Instruments), Origin (OriginLab Corporation) and in-house software
(Proks et al, 2005b). For homomeric Kir6.2-T293N/SUR1 channels, the
open probability in the absence of ATP (Po(0)) was determined from
single-channel patches as the fraction of time spent in the open state
for recordings of 1 min duration. Open time distributions were fit
with a single exponential; up to three exponentials were fitted to
dwell-time distributions. Burst durations were determined by using
the criterion for the critical time described previously (Magleby &
Pallotta, 1983).
For heterozygous Kir6.2-T294M/SUR1 channels, single-channel
amplitudes were calculated from an all-points current amplitude
histogram. Channel activity (NPo) was measured as the mean current
(I) divided by the single-channel amplitude (i) for current records of
1 min duration. Po(0) was calculated from NPo/N, where N is the
number of channels in the patch estimated from the maximum
number of superimposed events.
Cell-surface expression assay
Surface expression was performed on COS-7 cells transiently
expressing HA-tagged Kir6.2 and SUR1 (Zerangue et al, 1999). For
each experiment, three 35 mm dishes were transfected in parallel.
Forty-eight hours post-transfection, cells were fixed in 4% formalde-
hyde, and incubated with rat monoclonal anti-HA antibody (clone
3F10, Roche) and HRP-conjugated anti-rat secondary antibody
(Jackson laboratories). Bound antibodies were detected by femto
maximum sensitivity chemiluminescent substrate (Pierce) and quan-
titated using a Monolight 2010 luminometer. Results are the average 2009 EMBO Molecular Medicine 175
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176of three dishes per experiment, and each data point is the average of
three independent experiments.Author contributions
Kenju Shimomura performed all patch-clamp studies. Brittany
Zadek did the molecular biology for functional studies and
Roope Mannikko made Figure 8. Lejla Zubcevic and Christophe
Girard performed the surface expression analysis and Mark
Lethby the two-electrode voltage-clamp studies. Sarah Flana-
gan did the genetic analysis. Peter Clayton, Andrew Hattersley,
Khalid Hussain, Ritika Kapoor, Oliver Petz and Mars Skae
conducted the clinical investigations.
Frances Ashcroft directed the functional experiments, and
Andrew Hattersley and Sian Ellard directed the genetic
experiments. Frances Ashcroft and Sian Ellard wrote the paper,
which was then reviewed by all authors.Acknowledgements
We thank the Wellcome Trust (076436/Z/05/Z and 081188/A/
06/Z), the Royal Society and the European Union (EuroDia,
SHM-CT-2006-518513 and EDICT, 201924) for support. FMA is
a Royal Society Research Professor. Brittany Zadek was
supported by an OXION studentship and Sarah Flanagan by a
Sir Graham Wilkins Research Fellowship.
Supplementary information is available at EMBO Molecular
Medicine online.
The authors declare that they have no conflict of interest.For more informationOMIM, Online Mendelian Inheritance in Man:
KCNJ11:
http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=600937
Diabetes genes:
www.diabetesgenes.org
Diabetes UK homepage:
www.diabetes.org.uk
American Diabetes Association homepage:
www.diabetes.org
Frances Ashcroft’s Laboratory:
http://www.dpag.ox.ac.uk/research/transport/ashcroft/ashcroft_researchReferences
Antcliff JF, Haider S, Proks P, Sansom MS, Ashcroft FM (2005) Functional
analysis of a structural model of the ATP-binding site of the KATP channel
Kir6.2 subunit. EMBO J 24: 229-239
Ashcroft FM (2007) ATP-sensitive Kþ channels and disease: from molecule to
malady. Am J Physiol Endocrinol Metab 293: E880-889
Bahi-Buisson N, Eisermann M, Nivot S, Bellanne-Chantelot C, Dulac O, Bach N,
Plouin P, Chiron C, de Lonlay P (2007) Infantile spasms as an epileptic
feature of DEND syndrome associated with an activating mutation in the
potassium adenosine triphosphate (ATP) channel, Kir6.2. J Child Neurol 22:
1147-1150 2009 EMBO Molecular MedicineDe Leon DD, Stanley CA (2007) Mechanisms of Disease: advances in diagnosis
and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol
Metab 3: 57-68
Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A, Lindley KJ (2004)
Hyperinsulinism in infancy: from basic science to clinical disease. Physiol
Rev 84: 239-275
Enkvetchakul D, Loussouarn G, Makhina E, Shyng SL, Nichols CG (2000) The
kinetic and physical basis of KATP channel gating: toward a unified
molecular understanding. Biophys J 78: 2334-2348
Flanagan SE, Clauin S, Bellanne-Chantelot C, de Lonlay P, Harries LW, Gloyn AL,
Ellard S (2009) Update of mutations in the genes encoding the pancreatic
beta-cell KATP subunits Kir6.2 (KCNJ11) and sulfonylurea receptor
(ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat
30: 170-180.
Girard C, Shimomura K, Proks P, Absalom N, de Nanclares PG, Ashcroft FM
(2006) Functional analysis of six Kir6.2 (KCNJ11) mutations causing
neonatal diabetes. Pflugers Arch 453: 323-332
Girard CA, Wunderlich FT, Shimomura K, Collins S, Kaizik S, Proks P,
Abdulkader F, Clark A, Ball V, Zubcevic L, et al (2009) A mouse model of
neonatal diabetes caused by the KATP channel mutation Kir6.2-V59M. J Clin
Invest Dec 8, DOI: 10.1172/JCI35772
Gribble FM, Loussouam G, Tucker SJ, Zhao C, Nichols CG, Ashcroft FM (2000) A
novel method for measurement of submembrane ATP concentration. J Biol
Chem 29: 30046-30049
Gribble FM, Tucker SJ, Ashcroft FM (1997) The essential role of the Walker A
motifs of SUR1 in KATP channel activation by Mg-ADP and diazoxide. EMBO J
16: 1145-1152
Gribble FM, Tucker SJ, Haug T, Ashcroft FM (1998) MgATP activates the b-cell
KATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci USA
95: 7185-7190
Hattersley AT, Ashcroft FM (2005) Activating mutations in Kir6.2 and neonatal
diabetes: New clinical syndromes, new scientific insights, and new therapy.
Diabetes 54: 2503-2513
Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin
secretion by glucose. Diabetes 49: 1751-1760
Koster JC, Cadario F, Peruzzi C, Colombo C, Nichols CG, Barbetti F (2008) The
G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and
motor dysfunction in adulthood that is improved with sulfonylurea therapy.
J Clin Endocrinol Metab 93: 1054-1061
Koster JC, Marshall BA, Ensor N, Corbett JA, Nichols CG (2000) Targeted
overactivity of beta cell KATP channels induces profound neonatal diabetes.
Cell 100: 645-654
Lin YW, MacMullen C, Ganguly A, Stanley CA, Shyng SL (2006) A novel KCNJ11
mutation associated with congenital hyperinsulinism reduces the intrinsic
open probability of beta-cell ATP-sensitive potassium channels. J Biol Chem
28: 3006-3012
Magleby KL, Pallotta BS (1983) Burst kinetics of single calcium activated
potassium channels in cultured muscle. J Physiol 344: 605-623
Masia R, Koster JC, Tumini S, Chiarelli F, Colombo C, Nichols CG, Barbetti F
(2007) An ATP-binding mutation (G334D) in KCNJ11 is associated with a
sulfonylurea-insensitive form of developmental delay, epilepsy, and
neonatal diabetes. Diabetes 56: 328-336
Nichols CG (2006) KATP channels as molecular sensors of cellular metabolism.
Nature 440: 470-476
Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement JP, Gonzalez G,
AguilarBryan L, Permutt MA, Bryan J (1996) Adenosine diphosphate as an
intracellular regulator of insulin secretion. Science 272: 1785-1787
Nishida M, Cadene M, Chait BT, MacKinnon R (2007) Crystal structure of a
Kir3.1-prokaryotic Kir channel chimera. EMBO J 26: 4005-4015
Pearson ER, Flechtner I, Njolstad PR, Neonatal Diabetes International
Collaborative Group, Malecki MT, Flanagan S, Larkin B, Ashcroft FM, Klimes I,
Codner E, et al (2006) The successful transfer of insulin treated patients
with diabetes due to Kir6.2 (KCNJ11) mutations to sulphonylurea tablets. N
Eng J Med 355: 467-477EMBO Mol Med 1, 166–177 www.embomolmed.org
Research Article
Kenju Shimomura et al.Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Sleisinger PA,
Choe S (2005) Cytoplasmic domain structures of Kir2.1 and Kir3.1
show sites for modulating gating and rectification. Nat Neurosci 8:
279-287
Proks P, Girard C, Ashcroft FM (2005a) Enhanced activation by MgATP
contributes significantly to the functional effects of KCNJ11 mutations
causing neonatal diabetes. Hum Mol Genet 14: 2717-2726
Proks P, Girard C, Haider S, Gloyn AL, Hattersley AT, Sansom MSP, Ashcroft FM
(2005b) A novel gating mutation at the internal mouth of the Kir6.2 pore is
associated with DEND syndrome. EMBO Rep 6: 470-475
Shimomura K, Girard CAJ, Proks P, Nazim J, Lippiat JD, Cerutti F, Lorini
R, Ellard S, Hattersley A, Barbetti F, et al (2006) Mutations at the same
residue (R50) of Kir6.2 (KCNJ11) produce different functional effects. Diabetes
55: 1705-1712
Shyng S, Ferrigni T, Nichols CG (1997) Regulation of KATP channel activity by
diazoxide and MgADP. Distinct functions of the two nucleotide binding folds
of the sulfonylurea receptor. J Gen Physiol 110: 643-654
Shyng SL, Ferrigni T, Shepard JB, Nestorowicz A, Glaser B, Permutt MA, Nichols
CG (1998) Functional analyses of novel mutations in the sulfonylureawww.embomolmed.org EMBO Mol Med 1, 166–177receptor 1 associated with persistent hyperinsulinemic hypoglycemia of
infancy. Diabetes 47: 1145-1151
Tammaro P, Flanagan SE, Zadek B, Srinivasan S, Woodhead H, Hameed S,
Klimes I, Hattersley AT, Ellard S, Ashcroft FM (2008) A Kir6.2 mutation
causing severe functional effects in vitro produces neonatal diabetes
without the expected neurological complications. Diabetologia 51: 802-810
Trapp S, Tucker SJ, Ashcroft FM (1997) Activation and inhibition of K-ATP
currents by guanine nucleotides is mediated by different channel subunits.
Proc Natl Acad Sci USA 94: 8872-8877
Tucker SJ, Gribble FM, Zhao C, Trapp S, Ashcroft FM (1997) Truncation of Kir6.2
produces ATP-sensitive Kþ channels in the absence of the sulphonylurea
receptor. Nature 387: 179-183
Yan FF, Lin YW, MacMullen C, Ganguly A, Stanley CA, Shyng SL (2007)
Congenital hyperinsulinism associated ABCC8 mutations that cause
defective trafficking of ATP-sensitive Kþ channels: identification and rescue.
Diabetes 56: 2339-2348
Zerangue N, Schwappach B, Jan YN, Jan LY (1999) A new ER trafficking signal
regulates the subunit stoichiometry of plasma membrane KATP channels.
Neuron 22: 233-254 2009 EMBO Molecular Medicine 177
